# Epigenetics & Chromatin

Epigenetics & Chromatin is a peer-reviewed open access scientific journal published by BioMed Central that covers the biology of epigenetics and chromatin.

## Scope

Epigenetics & Chromatin is a peer-reviewed open access scientific journal that publishes research related to epigenetic inheritance and chromatin-based interactions. First published in 2008 by BioMed Central, its overall aim is to understand the regulation of gene and chromosomal elements during the processes of cell division, cell differentiation, and any alterations in the environment. To date, 13 volumes have been published.

## Usage

As of October 2020, there has been over 340,000 downloads and over 750 Altmetric mentions.

## Metrics
### Impact factor

According to Journal Citation Reports, it received an impact factor of 4.237 in 2019. Its current SCImago Journal Rank is 2.449.

### Citation impact

Its 2-year and 5-year citation impact factor is 4.237 and 4.763, respectively. Its Source Normalized Impact per Paper (SNIP) is 0.896.

## Editors

Its current Journal Authority Factor (JAF) is 111.5.

### Editors-in-Chief

| Editor | Institution |
| Frank Grosveld | Erasmus University Medical Center, Netherlands |
| Steven Henikoff | Fred Hutchinson Cancer Research Center, USA |

### Editorial Board

| Editor | Institution |
| Julie Ahringer | The Gurdon Institute, University of Cambridge, UK |
| Juan Ausió | University of Victoria, Canada |
| Shelley Berger | The Wistar Institute, USA |
| Timothy Bestor | Columbia University, USA |
| Yamini Dalal | National Cancer Institute, USA |
| Elzo de Wit | Netherlands Cancer Institute, The Netherlands |
| Jerome Dejardin | Institute of Human Genetics, France |
| Anne Ferguson-Smith | University of Cambridge, UK |
| Amanda Fisher | Imperial College London, UK |
| John Greally | Albert Einstein College of Medicine, USA |
| Shiv Grewal | National Institutes of Health, USA |
| Joost Gribnau | Erasmus University Medical Center, Netherlands |
| Gordon Hager | National Cancer Institute, USA |
| Steven Jacobsen | University of California, Los Angeles, USA |
| Albert Jeltsch | University of Stuttgart, Germany |
| Paul Kaufman | University of Massachusetts Medical School, USA |
| William Kelly | Emory University, USA |
| Siavash Kurdistani | University of California, Los Angeles, USA |
| Colin Logie | Radboud University Medical Centre, The Netherlands |
| Frank Lyko | German Cancer Research Center, Germany |
| Kazuhiro Maeshima | National Institute of Genetics, Japan |
| Valerio Orlando | King Abdullah University of Science and Technology, Saudi Arabia |
| Vincenzo Pirotta | Rutgers University, USA |
| Ana Pombo | Max Delbrueck Centre, Germany |
| Oliver Rando | Harvard FAS Center for Systems Biology, USA |
| Jasper Rine | University of California, Berkeley, USA |
| Wendy Robinson | BC Children's Hospital Research Institute, Canada |
| Yang Shi | Harvard Medical School, USA |
| David Spector | Cold Spring Harbor Laboratory, USA |
| Brian Strahl | University of North Carolina, USA |
| Azim Surani | The Wellcome Trust & Cancer Research UK, UK |
| David Tremethick | Australian National University, Australia |
| Jessica Tyler | MD Anderson Cancer Center, USA |
| Bas van Steensel | The Netherlands Cancer Institute, Netherlands |
| Jörn Walter | Universität des Saarlandes, Germany |
| Jerry Workman | Stowers Institute for Medical Research, USA |
| Anton Wutz | ETH Zurich, Switzerland |
| Rui-ming Xu | Chinese Academy of Sciences, China |
| Yi Zhang | Harvard Medical School, USA |

## Submission guidelines

Current submission guidelines are as follows:

### Prior to submitting

Submitters must ensure that Epigenetics & Chromatin is the most suitable journal for the proposed article in addition to understanding of the costs, funding options, and copyright agreement associated with submission. Accuracy and readability of the manuscript must also be considered.

### During the submission process

The manuscript must follow all formatting rules which authors must read, understand and accept.

### After successful submission

Authors should review the peer-review policy. Authors should also be familiar with the process of manuscript transfers to a different journal, as well as how to promote the publication.

### Speed of the submission process

On average, it takes 53 days to reach a decision for reviewed manuscripts and 35 days for all manuscripts. The process of acceptance takes an average of 112 days after submission. After acceptance, it takes an average of 16 days for an article to be published.

## Indexing services

After successful publication in Epigenetics & Chromatin, articles are also included in:
* Biological Abstracts
* Chemical Abstracts (CAS)
* Citebase
* Directory of Open Access Journals (DOAJ)
* Embase
* EMBiology
* MEDLINE
* OAIster
* PubMed
* PubMed Central (PMC)
* Science Citation Index Expanded
* Scopus
* SOCOLAR
* Zetoc (operated by Jisc)

## Notable publications

As of October 2020, the most accessed articles are:
* Chromatin accessibility: a window into the genome (Tsompana & Buck, 2014)
* Constitutive heterochromatin formation and transcription in mammals (Saksouk et al., 2015)
* Chromatin structure and DNA damage repair (Dinant et al., 2008)
* Profiling genome-wide DNA methylation (Yong et al., 2016)
* Additional annotation enhances potential for biologically relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip Array (Price et al., 2013)